Anavasi Diagnostics COVID Test and Molecular Detector Get Emergency Use Authorization
The FDA issued an Emergency Use Authorization for Anavasi Diagnostics’ AscencioDx COVID-19 Test and The AscencioDx Molecular Detector.
Read More
Search Results for: covid-19
CDC, Biobot Analytics Extend Wastewater Surveillance System Contract
The CDC extended its partnership with Biobot Analytics to bring COVID and mpox wastewater analysis to communities across the country.
Read More
New Diagnostic Test is 1,000 Times More Sensitive than Conventional Tests
Researchers developed ultrabright fluorescent nanolabels called plasmonic-fluors to overcome limitations in point-of-care diagnostic tests.
Read More
BD Gets FDA Emergency Use Authorization for COVID, Influenza, RSV Combination Test
BD received Emergency Use Authorization from the US FDA for a new molecular diagnostic combination test for respiratory viruses.
Read More
Faster Genomics-Based Diagnosis May Accelerate Treatment of Myeloid Neoplasms Patients
Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients.
Read More